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Injection of low and iso-osmolar contrast medium decreases oxygen
tension in the renal medulla. The oxygen tension (PO2) in the renal cortex
and outer renal medulla in 26 rats was studied by use of oxygen
microelectrodes before and after injection of x-ray contrast media (CM).
The CM, iopromide, ioxaglate and iotrolan were administrated intrave-
nously in iodine equivalent doses (1,600 mg iodine/kg body wt). Ringer’s
solution was used as the control. In the outer medulla, all three CM
induced a decrease in PO2: iopromide (N 5 6) from 30 6 3 to 18 6 4 mm
Hg; ioxaglate (N 5 7) from 32 6 6 to 15 6 4 mm Hg; and iotrolan (N 5
6) from 36 6 3 to 14 6 4 mm Hg. All these decreases were significant.
After the injection of Ringer’s (N 5 7) there was an increase from 34 6
3 to 35 6 3 mm Hg. In the cortex a slight decrease was noted after
injection of CM, but this was significant only after injection of iotrolan. All
tested contrast media decrease PO2 in the outer renal medulla, which may
partly explain contrast medium-induced acute renal failure.
Circulatory events in the renal medulla, eventually leading to
medullary hypoxia, have been suggested as a possible mechanism
underlying contrast medium-induced acute renal failure (CM-
ARF). In previous studies we have found a reduction in renal
medullary blood flow following injection of CM [1, 2]. In 1991
Heyman et al [3] reported that an injection of the high-osmolar
contrast medium iotholamate led to a decrease in PO2 in the
outer renal medulla. After the introduction of the low-osmolar
CM there was a hope that these compounds would be less
nephrotoxic than the more hyperosmolar ones, and in a recent
prospective study [4] iohexol was indeed found to have less
influence on serum creatinine than diatrizoate. Even if there was
no significant difference between these CM with respect to the
occurrence of severe ARF (requiring dialysis), the meta-analysis
of Barrett and Carlisle [5] indicated that use of low-osmolar
contrast media may also prevent severe changes in renal function
in patients with pre-existing renal function. In this study we have
tested the hypothesis that the low and iso-osmolar CM also
decrease PO2 in the outer medulla.
The CM investigated were ioxaglate (ionic ratio 3.0), iopromide
(nonionic ratio 3.0), and iotrolan (nonionic ratio 6.0) (Table 1).
METHODS
Animals
The studies were performed on 26 male Lewis-DA rats with an
average body wt of 293 (6 4) g. The animals had free access to tap
water and standard chow containing 3 g Na/kg, 8 g K/kg, 21%
protein and 13 3 106 Joule/kg (R3, Ewos, So¨derta¨lje, Sweden), up
until the day of the experiment. They were anesthetized with
Inactin® (Byk-Gulden, Konstanz, Germany), given intraperitone-
ally at a dose of 120 mg/kg body wt. Tracheostomy was performed
and the rat was placed on a servo-controlled heating pad to
maintain the body temperature at 37.5°C.
Surgical procedures
A polyethylene catheter was placed in the left femoral artery for
blood sampling and monitoring of blood pressure. The left
femoral vein was catheterized for infusion of Ringer solution (0.5
ml/hr/100 g body wt) composed of 120 mM NaCl, 2.5 mM KCl, 25
mM NaHCO3 and 0.75 mM CaCl2. The right femoral vein was
catheterized for infusion of CM. The urinary bladder was cathe-
terized for collection of urine. The left kidney was exposed by a
left sub-costal flank incision and immobilized in a plastic cup. The
kidney was embedded in pieces of cotton wool soaked in Ringer
solution and its surface was covered with paraffin oil. During the
experiment the temperature of the kidney was monitored with a
thermocouple probe.
Oxygen microelectrode
The oxygen microelectrodes used in this study were modified
Clarke-type [6] electrodes, constructed as described by Revsbech
[7] and used in the kidney as described in a previous report [8].
They had a tip diameter of 2 to 8 mm and an inner luminal
diameter at the tip of 1 to 2 mm. The electrodes were polarized at
20.800 V, an electrical potential in which a linear response is
observed between the oxygen tension and the electrode current.
The current was measured by pico-amperemeters (University of
Aarhus, Denmark). The electrodes were calibrated in water at
37°C bubbled with N2 gas or air before and after the experiments.
The electrode current in N2 gas was 10 (6 1.1) pA, and in air 239
(6 28) pA. The stirring effect in bubbling water was 1.3% (6 0.3).
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Experimental protocol
When the surgical procedure was completed, the animal was
allowed to recover for 30 minutes. Subsequently, after a 20-
minute control period, a 30-minute experimental period started
with an eight minute injection of CM or control substance (Fig.
1.). The CM tested were: iopromide, 370 mg/ml (Ultravist®;
Schering, Berlin, Germany); ioxaglate, 320 mg/ml (Hexabrix®;
Laboratories Guerbet, Aulnay-sous-Bois, France) and iotrolan,
300 mg/ml (Isovist®; Schering). All CM were given in a dosage of
1,600 mg iodine/kg body wt, which is about 5 ml CM/kg body wt
of a 300 mg I/ml CM in a 60 kg person. Such doses are not unusual
in angiographic practise. Ringer’s solution was used as a control
(Table 1). All solutions were at room temperature when injected.
Throughout the experiment the oxygen tension in the renal cortex
and outer medulla and the blood pressure, body temperature and
kidney temperature were recorded continuously with a MacLab
Instrument (AD Instruments, Hastings, UK) connected to a
Macintosh Power-PC 6100. The oxygen tension (PO2) was mea-
sured at a depth of 1.0 mm in the cortex and at an average depth
of 3.9 mm (range 3.5 to 4.5) in the inner stripe of the outer
medulla. After each experiment the average PO2 for one minute
at the times 20, 15, 10, 5 and one minute before injection of CM
or control substance and 1, 5, 10, 15, 20, 25 and 30 minutes after
this injection was analyzed. At the end of the experiments, the
microelectrodes were replaced by empty outer microelectrode
casings with the same shape and size, placed on the same
micro-manipulator and inserted at the same depth. After injection
of a small amount of India ink, the outer casings were removed
and the kidney was sectioned in order to verify that the measure-
ments had been made at the intended sites, that is, in the cortex
and in the inner stripe of the outer medulla. If it was found that
the tips of the microelectrodes had not been in the appropriate
places, the measurements were excluded.
Blood and urine analysis
The urine volumes were measured gravimetrically. The urine
sodium and potassium concentrations were measured by flame
photometry (IL 543; Instrumentation Lab, Milano, Italy). Urine
osmolality was determined by the freezing point depression
method (Model 3MO; Advanced Instruments, Lexington, MA,
USA). One urine sample was taken before injection of CM and
three samples after this injection. Blood samples for hematocrit
measurement were taken before and after injection of CM.
Statistical evaluation
Values are expressed as means 6 SEM. The statistical signifi-
cance of the data were tested by using a multivariate analysis of
variance (MANOVA) model, comparing results obtained during
the control period with those obtained after drug administration
(repeated measures). For comparison of data between groups of
animals a two-tail Student’s t-test for unpaired samples was
applied. The JMP software from the SAS Institute was used [9]. A
P value of , 0.05 was accepted as significant in all analyses.
RESULTS
Oxygen tension in the cortex
As seen in Table 2 and Figure 2, all CM induced a slight
decrease in PO2 in the cortex. This decrease was not significant in
the ioxaglate or iopromide groups. In the iotrolan group it was
significant 15 and 20 minutes after the injection, but not subse-
quently. Ringer caused no significant changes.
Oxygen tension in the medulla
All CM induced a significant decrease in PO2 in the outer
medulla: iopromide (N 5 6) from 30 6 3 to 18 6 4 mm Hg;
ioxaglate (N 5 7) from 32 6 6 to 15 6 4 mm Hg; and iotrolan
(N 5 6) from 36 6 3 to 14 6 4 mm Hg. No significant difference
was found between the tested CM. After injection of Ringer (N 5
7) there was an increase from 34 6 3 to 35 6 3 mm Hg (Table 2
and Figure 3).
Urine and blood data
The results are summarized in Table 3. Urine flow increased
from 21- to 28-fold after injection of ioxaglate and iopromide.
After iotrolan injection it increased threefold and after injection
of Ringer’s 1.5-fold. Urine sodium output increased 13- to 43-fold
after iopromide and ioxaglate injection and 1.7-fold after injection
of iotrolan, respectively. The increases in urine flow and urine
sodium excretion were significant in all but the Ringer group.
Urine potassium output increased 6- and 27-fold after injection of
iopromide and ioxaglate, respectively, and 2.1-fold after Ringer
injection. All these increases were significant. In the iotrolan
group there was only a slight nonsignificant increase after the
injection. Urine osmolality decreased significantly in all groups
except the Ringer group. There was no change in hematocrit in
any of the groups.
DISCUSSION
During the last decade, new, less hyperosmotic and more
expensive contrast media have been introduced. These have
brought an improvement for the patients in that they cause less
discomfort [10]. In patients with normal renal function, the risk of
developing ARF after injection of contrast media is equally low
with both low and high osmolar contrast media [5]. In several
recent studies [4, 5, 11–14] it has been found that renal function,
when monitored in terms of creatinine clearance or serum creat-
inine, is affected less by injections of low-osmolar CM than by
high-osmolar CM. Nevertheless, no study has yet shown any
statistical difference concerning the incidence of severe acute
renal failure (requiring dialysis) between high and low osmolar
CM, though the meta-analysis of Barrett and Carlisle indicated
that use of low osmolar contrast media may also prevent severe
changes in renal function [5].
In 1991 Heyman et al [3] observed a decrease in PO2 in the
renal outer medulla in salt-depleted uninephrectomized rats
following injection of the ionic, hyperosmolar monomeric contrast
medium iotholamate. They found a PO2 level of 26 6 3 mm Hg in
Table 1. Tested substances
Substance
Type of
contrast medium
Iodine conc.
mg/ml
Osmolality
mOsm/kg
Iopromidea (Ultravistt) Non-ionic 370 774
Monomer
Ioxaglatea (Hexabrixt) Ionic 320 580
Dimer
Iotrolana (Isovistt) Non-ionic 300 320
Dimer
Ringer — 0 310
a Data are from the manufacturer
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the inner stripe of the outer medulla and after injection of
iothalamate they noted levels of 9 6 2 mm Hg. On an average the
reduction in PO2, seen in Heyman et al’s study [3] is similar to that
in the present study. A PO2 level of about 10 mm Hg is not
necessarily harmful. The normal PO2 in the muscle is about 10
mm Hg [15]. However, in the outer medullary region, with its high
metabolic activity, a decrease may be injurious, as indicated by the
morphological correlate to the decrease in PO2 in the outer
medulla reported by Alcorn et al [16], who described a specific
lesion in the cells of the thick ascending limb (mTAL) of the loop
of Henle, in the outer medulla, characterized by features ranging
from mitochondrial swelling to nuclear pyknosis and cell death in
renal in vitro perfusion studies. These findings were confirmed by
Brezis et al [17–19], who found that the more severe the ischemia
the more pronounced the injury and that the injury decreased in
severity in kidneys given a high oxygen supply.
The reduction in PO2 in the outer medulla after injection of
CM may be explained by different mechanisms. As hyperosmolar
compounds, CM act as osmotic diuretics, freely filtered by the
glomeruli and poorly absorbed by the renal tubule, the high CM
concentration in the tubule will reduce the reabsorption of water
and sodium from the tubule and induce an osmotic diuresis. As a
result of the osmotic effect, the amount of sodium arriving at
mTAL will increase, and hence also the active uptake from mTAL
[20], leading to a further decrease in PO2 in the outer medulla [3,
21–23]. As seen in Table 3, in our study significant natriuresis
occurred after injection of all CM, although the natriuresis caused
by iotrolan was only about one-tenth of that produced by ioxaglate
and iopromide. This indicates that this explanation for a decrease
in PO2 is not plausible in the case of iotrolan.
Another possible mechanism underlying a decrease in PO2 in
the kidney is a reduction in blood flow. All major vascular beds,
except in the kidney, respond to CM and hyperosmolar com-
pounds with a transient vasodilation [24]. The blood flow may be
Fig. 1. Experimental protocol.
Fig. 2. Effects of injection of different contrast media and Ringer solu-
tion (control) on PO2 (mm Hg) in the renal cortex. Symbols are: (f)
ioxaglate (N 5 7); (l) iopromide (N 5 6); () iotrolan (N 5 6); ()
Ringer’s solution (N 5 7).
Fig. 3. Effects of injection of different contrast media and Ringer solu-
tion (control) on PO2 (mm Hg) in the renal medulla. Symbols are: (f)
ioxaglate (N 5 6); (l) iopromide (N 5 7); () iotrolan (N 5 6); ()
Ringer’s solution (N 5 7).
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decreased by rheological effects. We have recently observed
aggregation in inner medullary vessels [2]. Trapping (that is,
cessation of blood flow in capillaries due to tightly packed red
blood cells) is another rheological phenomenon that has been
shown to occur in the outer medulla after injection of all types of
CM [2, 25]. In the inner medulla [1, 2], we found that the nonionic
CM decreased the blood flow and induced aggregation to a
greater extent than the ionic CM ioxaglate. In the case of all CM,
red blood cell aggregation and trapping may have contributed,
either directly or indirectly, to a decrease in blood flow to the PO2
reduction seen in the present study.
Osmotic diuresis with a highly increased urine flow, distending
the tubules and collecting ducts may lead to renal swelling and a
rise in intrarenal venous pressure [26], resulting in a decrease in
blood flow. In our study, this mechanism may be valid for the
compounds causing pronounced diuresis and hence less valid for
iotrolan (Table 3).
Contrast media (CM) are hyperviscous solutions, that is, the
more concentrated, the more viscous. The new, iso-osmotic
nonionic dimer iotrolan, which because of its isotonicity results in
the least diuresis (Table 3), will consequently appear in the
highest concentration in the tubules. This will lead to a high
intratubular viscosity, the resulting viscosity also being a conse-
quence of the large size of the dimeric iotrolan molecule. This has
been shown by Ueda et al [27] to result in an extremely high
intratubular hydrostatic pressure. We propose that by this action
iotrolan may reduce renal blood flow, secondary to an increase in
intrarenal pressure and consequently a decrease in PO2. As an
iso-osmotic agent, iotrolan will be concentrated in the tubules,
and despite having a low LD50 [28] it will be in a more concen-
trated form than other CM with higher LD50, which may affect the
local cells. The increase in osmolar excretion after iotrolan-
injection was only 30%, but despite this there was a marked
decrease in urine osmolality (UOsm). In the ioxaglate and iopro-
mide groups the osmolar excretion increases are 13-fold and
10.3-fold and after Ringer injection twofold. Concerning the
ioxaglate and iopromide compounds their effect on UOsm may be
explained by their diuretic action, with the iotrolan compound this
cannot be the case, as iotrolan has a low diuretic effect. Thus, a
functional impairment secondary to hypoxia in the thick ascend-
ing limb of the loop of Henle may be an explanation for this
inability to concentrate the urine.
Other possible contributors to a decrease in renal blood flow in
response to administration of CM are increases in calcium [29],
adenosine [14, 30] and endothelin [31], and decreased production
of nitric oxide [32]. These parameters were not measured in the
present study and, thus, the extent to which these mechanisms
might have influenced the results cannot be determined.
Agmon et al have reported an increase in outer medullary
blood flow, measured by laser-Doppler probes, following injection
Table 2. Oxygen tension (PO2, mm Hg) in the renal cortex and outer medulla before (control value) and after injection of contrast media
Ioxaglate (N 5 7)
(Hexabrixt)
Iopromide (N 5 6)
(Ultravistt)
Iotrolan (N 5 6)
(Isovistt) Ringer (N 5 7)
Renal cortex
PO2 before CM 45 6 5 (100%) 43 6 7 (100%) 50 6 4 (100%) 45 6 5 (100%)
PO2 after CM
a 38 6 2 (84%) 40 6 4 (93%) 38 6 5 (76%)b 41 6 4 (91%)
Outer medulla
PO2 before CM 32 6 6 (100%) 30 6 3 (100%) 36 6 3 (100%) 34 6 3 (100%)
PO2 after CM
a 15 6 4 (47%)b 18 6 4 (60%)b 14 6 4 (39%)b 35 6 3 (103%)
Ringer’s solution was used as the control. Percentages are relative values. Control level is 100%.
a Average of the three last observations (20, 25 and 30 min) after CM or Ringer’s solution
b Indicates a significant difference (P , 0.05) compared with the control period
Table 3. Effects of injection of different contrast media (CM) and Ringer’s solution on urine flow, sodium excretion, potassium excretion, urine
osmolality and hematocrit
Ioxaglate (N 5 7)
(Hexabrixt)
Iopromide (N 5 6)
(Ultravistt)
Iotrolan (N 5 6)
(Isovistt) Ringer’s (N 5 7)
Urine flow ml/min
Before CM 2.1 6 0.2 3.2 6 0.9 2.8 6 0.5 2.2 6 0.2
After CMa 59.4 6 9.9b 71.1 6 3.0b 9.1 6 2.9b 3.4 6 0.5
Sodium excretion mmol/min
Before CM 0.07 6 0.01 0.08 6 0.02 0.13 6 0.05 0.09 6 0.03
After CMa 3.0 6 0.28b 1.03 6 0.21 0.22 6 0.08b 0.11 6 0.02
Potassium excretion mmol/min
Before CM 0.16 6 0.05 0.27 6 0.07 0.34 6 0.12 0.30 6 0.08
After CM 4.4 6 0.49b 1.67 6 0.14b 0.35 6 0.09 0.63 6 0.14b
UOsm mOsm/kg
Before CM 1747 6 184 1813 6 170 2403 6 374 2005 6 240
After CMa 819 6 48b 845 6 41b 967 6 267b 2647 6 132b
Hematocrit %
Before CM 51 6 1 50 6 1 50 6 1 52 6 1
After CMa 53 6 1 51 6 1 52 6 1 51 6 1
a Maximal change
b Significantly difference (P , 0.05) compared with the control period
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of iothalamate [33] given in a dose of 2.900 mg I/kg body wt during
two minutes. These findings may be explained if the higher
metabolic demand increased out of proportion to the increase in
blood flow. Other studies have demonstrated outer medullary
trapping of red blood cells following the administration of con-
trast media [3, 34], indicating that there is a decrease in blood flow
in the outer medulla after CM injection.
These experimental observations that, analogously to high-
osmolar CM, the low-osmolar and iso-osmolar CM induce a
decrease in PO2 in the renal medulla, thus indicate that hypoxia in
the medulla may explain the acute renal failure seen after
administration of these compounds.
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